Yahoo
NYSE - Delayed Quote USD

The Cigna Group (CI)

298.23 -0.18 (-0.06%)
At close: 4:00:02 PM EDT
298.47 +0.24 (+0.08%)
After hours: 4:24:20 PM EDT
Trade CI on Coinbase
Chart Range Bar
Loading chart for CI

What's happening with CI?

14m ago
Powered by Yahoo Scout

Cigna’s near-term focus centers on its November 5, 2026 third-quarter earnings report. Analysts expect revenue growth but lower earnings per share, while investors continue weighing Evernorth profitability, medical-cost pressure, regulatory risks, and Cigna’s longer-term modernization strategy. Cigna also joined other companies opposing plans to list tokenized versions of its shares.

Powered by Yahoo Scout
  • Previous Close 298.41
  • Open 302.79
  • Bid 294.00 x 12000
  • Ask 298.45 x 16000
  • Day's Range 297.38 - 303.42
  • 52 Week Range 239.51 - 316.27
  • Volume 1,821,476
  • Avg. Volume 1,619,553
  • Market Cap (intraday) 78.804B
  • Beta (5Y Monthly) 0.30
  • PE Ratio (TTM) 12.33
  • EPS (TTM) 24.19
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield 6.24 (2.09%)
  • 1y Target Est 342.29
  • Morningstar Rating Rating available with Stock Picks access

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

www.thecignagroup.com

65,669

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CI
10.19%
S&P 500 (^GSPC)
10.73%

1-Year Return

CI
23.43%
S&P 500 (^GSPC)
11.11%

3-Year Return

CI
3.56%
S&P 500 (^GSPC)
81.91%

5-Year Return

CI
53.22%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 71.67B
Earnings 1.66B
Profit Margin 2.32%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20B
40B
60B
1.8%
2.0%
2.2%
2.4%
2.6%

Analyst Insights

View More

Analyst Price Targets

288.00
342.29 Average
298.23 Current
400.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/2/2026
Analyst Piper Sandler
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 346 -> 370

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.27%

  • Return on Assets (ttm)

    4.46%

  • Return on Equity (ttm)

    16.76%

  • Revenue (ttm)

    282.38B

  • Net Income Avi to Common (ttm)

    6.42B

  • Diluted EPS (ttm)

    24.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.26B

  • Total Debt/Equity (mrq)

    74.29%

  • Levered Free Cash Flow (ttm)

    7.98B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: